e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Chronic airway disease: markers of disease impact
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Examining the specificity of an internally quenched fluorogenic substrate for neutrophil elastase
C. Robb (Belfast, United Kingdom)
Source:
International Congress 2017 – Chronic airway disease: markers of disease impact
Session:
Chronic airway disease: markers of disease impact
Session type:
Thematic Poster
Number:
4000
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Robb (Belfast, United Kingdom). Examining the specificity of an internally quenched fluorogenic substrate for neutrophil elastase. 4000
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Investigating optimal sputum processing methods for active neutrophil elastase quantification
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
An innovative high sensitivity tool for active neutrophil elastase quantification
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Matrix metalloproteinase -9 and neutrophil elastase complexed with α
1
- inhibitor proteinase in children with recurrent upper respiratory tract diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011
Thrombin activatable fibrinolytic inhibitor in sera from NSCLC patients
Source: Eur Respir J 2005; 26: Suppl. 49, 91s
Year: 2005
Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation
Source: Eur Respir J 2003; 22: 739-742
Year: 2003
A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
The antimicrobial peptide LL-37 modulates inflammatory reaction and amplifies ROS of human neutrophils
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Development of a novel immunoassay for the measurement of active plasmin in patients with IPF
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Carbocysteine and N-acetyl cysteine inhibit cigarette smoke mediated acetylation of the PMN chemoattractant peptide PGP
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
Candidacidal activity of polymorphonuclear granulocytes (PMNs) and
Candida
hydrolytic enzymes in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
Increased detection of interleukin-;5 in sputum by addition of protease inhibitors
Source: Eur Respir J 2001; 18: 685-691
Year: 2001
Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase
Source: Eur Respir J 2002; 19: 1136-1141
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept